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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYTherapeutic approaches for ‘‘sick sinus syndrome’’ rely on electrical pacemakers, which lack hormone responsiveness and bear hazards
such as infection and battery failure. These issues may be overcome via ‘‘biological pacemakers’’ derived from pluripotent stem cells
(PSCs). Here, we show that forward programming of PSCs with the nodal cell inducer TBX3 plus an additional Myh6-promoter-based
antibiotic selection leads to cardiomyocyte aggregates consisting of >80% physiologically and pharmacologically functional pacemaker
cells. These induced sinoatrial bodies (iSABs) exhibited highly increased beating rates (300–400 bpm), coming close to those found in
mouse hearts, and were able to robustly pace myocardium ex vivo. Our study introduces iSABs as highly pure, functional nodal tissue
that is derived from PSCs and may be important for future cell therapies and drug testing in vitro.INTRODUCTION
‘‘Sick sinus syndrome’’ is used as a collective term to
describe a number of diseases caused by perturbed function
of the sinus node, which represents the cardiac pacemaker.
This structure is composed of specialized cardiomyocytes
innervated by autonomic nerves. The diseases include
pathological and/or symptomatic sinus bradycardia, sino-
atrial (SA) block, sinus arrest, and tachycardia-bradycardia
syndrome. Sick sinus syndrome is often accompanied by
general cardiac diseases such as ischemic heart disease,
cardiomyopathy, and myocarditis. These result in either
disturbed pacemaking within the sinus node or disturbed
conduction of the electric impulse from the sinus node to
the atrium (also known as SA conduction disturbance). At
present, therapeutic approaches for sick sinus syndrome
rely on the implantation of artificial pacemakers, which
are insensitive to hormone stimulation. Furthermore, the
hazards of infection and battery failure are potential
limitations. Therefore, patients with an implanted pace-
maker generally bear a risk of developing severe complica-
tions during their remaining lifespan.
To avoid these hazards, the availability of functional SA
node (SAN) cells for transplantation or the de novo gener-
ation of such cells in vivo is required. Correspondingly, to
obtain biological pacemaker cells for future therapy, two
possible approaches are being addressed. One approach is
to convert beating myocardium into pacemaker cells592 Stem Cell Reports j Vol. 2 j 592–605 j May 6, 2014 j ª2014 The Authorsin situ via genetic manipulations (i.e., direct reprogram-
ming). In this regard, the early key transcription factor
TBX3 led to cells with incomplete pacemaker character-
istics (Bakker et al., 2012). More recently, viral overex-
pression of TBX18, a member of the same transcription
factor family, was reported to enable reprogramming of
chamber myocardium toward nodal cells (Kapoor et al.,
2013). Thus far, however, this approach requires integra-
tion of viruses, prohibiting a spatially and timely con-
trollable expression of TBX18, which would mimic the
in vivo situation in the developing embryo. TBX18 is
only transiently expressed in the head part of the devel-
oping sinus node, whereas TBX3 is permanently expressed
in the entire node in vivo (Wiese et al., 2009). In addition,
the efficiency of Tbx18-based direct reprogramming is low
(Kapoor et al., 2013).
Another approach relies on the transplantation of
in-vitro-generated ‘‘biological pacemakers’’ derived from
pluripotent stem cells (PSCs) such as embryonic stem cells
(ESCs) (Wobus et al., 1991; Kehat et al., 2002). In this re-
gard, Kleger et al. (2010) postulated that the small-molecule
compound EBIO enhances the formation of nodal cells
from murine ESCs to some extent. However, they did not
address the actual ability of the cells to pace ventricular
myocardium, and again the cells’ beating rates were low.
Moreover, on the electrophysiological level, they did not
discriminate between relatively mature pacemaker cells
and similar spontaneously contracting early/intermediate
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and Franz, 2012).
More recently, a cell population purified based on Alcam
(CD166) expression was described to give rise to nodal cells
(Scavone et al., 2013). It will be interesting to see whether
this approach can be transferred to the human system, as
surface marker expression specificity often differs among
species.
As an alternative, in this work we further developed our
previous method for cardiomyocyte-subtype forward pro-
gramming of ESCs via single transcription factors (David
et al., 2008, 2009; David and Franz, 2012). We applied
this approach to TBX3 and found that it led to a doubling
of functional pacemaker cells, but alone was still insuffi-
cient to obtain pure populations of these cells. This may
be related to the insufficiency of TBX3 as a single factor
for direct reprogramming (Bakker et al., 2012).
However, when we combined our approach with Myh6
promoter-based antibiotic selection (Klug et al., 1996), we
achieved cell aggregates that consisted exclusively of spon-
taneously beating cardiomyocytes, with beats per minute
(bpm) rates close to those of a mouse heart. Of these cells,
>80% corresponded to the desired pacemaker phenotypes
bearing full functionality at the levels of protein expres-
sion, electrophysiological parameters, and Ca2+ signaling
characteristics, as well as potency to robustly pace murine
myocardium ex vivo. Therefore, we provide and example
of highly enriched, stem cell-derived pacemaker cell popu-
lations that possess all of the properties characteristic of
that cell type, which may be an important prerequisite
for future cell therapies and in vitro drug evaluation.RESULTS
Relying on the high conservation of vertebrate TBX3 pro-
teins, we used human TBX3 in murine ESCs due to its
specific traceability. We inserted human TBX3 cDNA into
the pEF-DEST51 vector (Invitrogen) for EF1a-promoter-
based stable and constitutive overexpression in ESCs. Out
of 20 independent clones, we selected four clones that
represented the entire spectrum, ranging from low to
high levels of TBX3mRNA overexpression based on quan-
titative RT-PCR (qRT-PCR; Figure 1A). These overexpression
levels were confirmed on the protein level (Figure 1B). Fluo-
rescence-activated cell sorting (FACS) analyses showed no
influence of TBX3 overexpression on the numbers of
pluripotency marker Oct-4/Pou5f1 and Sox2-positive cells
(Figure 1C). This corresponds to normal undifferentiated
colony growth in leukemia inhibitory factor (LIF)-
containing medium (Figure 1B) and is in agreement with
our previous findings for MESP1 and NKX2-5 overexpres-
sion (David et al., 2008, 2009; David and Franz, 2012).SteWe concluded that similar to what was found for those
factors, TBX3 alone was not sufficient to induce differenti-
ation of ESCs.
During differentiation, highly and moderately TBX3-
overexpressing ESC clones started to contract earlier and
showed approximately 5- to 10-foldmore contracting areas
than controls (Figure 2A). This enhanced cardiac differen-
tiation resembles the effect of MESP1 and NKX2-5 overex-
pression described in our previous studies (David et al.,
2008, 2009; David and Franz, 2012). Correspondingly to
their beating activity, Tbx3-overexpressing cardiomyocytes
showed a normal pattern of the sarcomeric marker MYH6
(Figure 2B).
To further verify the functionality and subtype content
of the cardiomyocytes, we analyzed their electrophysio-
logical properties via single-cell patch clamping and
‘‘funny channel’’ densitymeasurements at day 6+12 as pre-
viously described (David et al., 2008, 2009, 2013).
In general, three cell types that have been described for
isolated beating cardiomyocytes obtained from embryoid
body (EB) development, namely, ventricle-like, atrial-like,
and SA/AV (pacemaker-like) cells, plus intermediate cells
were present in preparations from TBX3 cell clones (Fig-
ure 2C). The action potentials (APs) generated by the
various cell types were typical with respect to their distinct
parameters, including the maximum diastolic potential
(MDP), diastolic depolarization rate (DDR), overshoot or
AP/plateau duration, and cycle length (Figure 2C; Figure S1
and Table S1 available online). However, we found an un-
usually high proportion of the pacemaker-like subtype in
TBX3 programmed cells, representing 38.5% of all cardio-
myocytes. These cells lacked a plateau phase, had a positive
MDP of >50mV, andhighDDRvalues typically exceeding
100 mV/s. In addition, they had the smallest positive over-
shoot, with a maximum of +20 mV. In contrast, within
control cells, only 20% of these pacemaker-like cells were
found (Table S2). In accordance with the high proportion
of pacemaker cells, cell numbers expressing HCN4 (repre-
senting the funny channel) were enhanced among the
Tbx3 programmed cardiomyocytes (Figure 2D).
To further enhance the yield of the SA/AV subtype
achieved via TBX3 programming, we chose to combine
this approach with MYH6-promoter-based antibiotic se-
lection (Klug et al., 1996). This was recently described
as directed pacemaker cell enrichment (Kensah et al.,
2013; Otsuji et al., 2010). We therefore additionally intro-
duced the plasmid containing the Myh6-Neomycin
cassette (Klug et al., 1996) into our TBX3 clones. As
expected, administration of the antibiotic during differ-
entiation led to an enrichment of beating tissue in
Myh6-promoter antibiotic-selected controls. Likewise,
Myh6-TBX3 double-transgenic clones were enriched for
beating foci (Movies S1 and S2). However, in the latter,m Cell Reports j Vol. 2 j 592–605 j May 6, 2014 j ª2014 The Authors 593
Figure 1. Functionality of the TBX3 Overexpression Construct in ESCs
(A) Twenty independent cell clones were stably transfected with an overexpression construct bearing the human TBX3-cDNA.
Overexpression levels were analyzed via qRT-PCR. Four representative clones were selected for further analysis. The data represent two
biological replicates and are presented as means ± SD.
(B) Immunostaining of overexpressed TBX3 (red), Actin (green), and nuclei (blue) in the four selected clones confirm overexpression levels
of TBX3. Scale bar, 10 mm.
(C) FACS analyses of OCT-4/POU5f1 and SOX2 reveal no influence of TBX3 overexpression on pluripotency under LIF administration. The
data represent five independent experiments and are presented as means ± SEM.
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(Figure 3A). After introduction of an additional dissocia-
tion step, beating rates increased in Myh6-promoter
antibiotic-selected controls, leading to antibiotic-selected
cardiac bodies (aCaBs), as well as in Myh6-Tbx3 double-
transgenic clones. In the latter, we often found cellular
aggregates contracting at 300–400 bpm, which is 6-
fold faster than wild-type cells. These beating rates
come close to murine heart rates (500 bpm), indicating
the formation of induced SA bodies (iSABs; Figure 3A;
Movie S3). The cells within iSABs were positive for
HCN4 as well as for Connexins CX45 and CX30.2 (Fig-594 Stem Cell Reports j Vol. 2 j 592–605 j May 6, 2014 j ª2014 The Authorsure 3B) which is characteristic for pacemaker cells (Kreuz-
berg et al., 2005; Verheijck et al., 2001).
Further cultivation of iSABs for 3 weeks on gelatin-coated
dishes led to attached, highly synchronized cell layers
beating at >350 bpm (Movie S4). The cells exhibited the
typical shape of nodal cells (i.e., spindle and spider-shaped
cells; Figure 3C; Movie S5).
To address the electrophysiological parameters of
iSAB-derived cardiomyocytes, we performed single-cell
patch clamping again. Out of 65 cells analyzed, 53 cells
(81.5%) now corresponded to the regular and fast-beating
pacemaker subtype, and only 12 cells (18.5%) represented
Figure 2. Dominant Appearance of Pacemaker-like Cardiomyocytes in TBX3-Programmed ESCs
(A) Spontaneous beating activity is increased in independent TBX3 clones and control ESCs (GSES). The data represent five independent
experiments and are presented as means ± SEM; *p < 0.05, **p < 0.01 ***p < 0.001; number of EBs > 100.
(B) Confocal analysis of MYH6 expression in control and TBX3-overexpressing cardiomyocytes (red). Counterstaining against Actin (green)
and nuclei (blue). Scale bar, 10 mm.
(C) Distribution of cardiomyocyte subtypes and examples of the four APs as shown by single-cell patch-clamping analyses. In a total of 39
cells, 38.5% of pacemaker-like cells were obtained. Ventr., ventricular-like (23.1%); Atr., atrial-like (8%); Pace., SAN-like (38.5%); In-
term., intermediate/early type (38.8%).
(D) HCN4-expressing cells are increased significantly in Tbx3 clones at day 18. The data represent five independent experiments and are
presented as means ± SD; **p < 0.01.
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Moreover, 43 of the 53 cells classified as the pacemaker-
system subtype showed AP parameters of mature pace-
maker cells, whereas ten of these spontaneously and
regularly beating cells were still immature (Figures 4A and
S2; Table S3). The latter exhibited a short plateau phase
and a more negative MDP, which distinguishes them
from fully mature pacemaker cells. Yet, they also showed
typical pacemaker features, such as regular spontaneous
AP generation with a fast DDR, and expressed the typical
pacemaker current If comparably to the cells classified as
mature pacemaker cells (Figures 4B–4E). Likewise, the
iSAB-derived cells responded to isoproterenol and carba-
chol with an acceleration and deceleration, respectively,Steof AP rates (Figure 4F). Thus, the beating rates were able
to reach >550 bpm.
To further verify the pacemaker cell identity, we charac-
terized the Ca2+ flux from the extracellular space and
intracellular Ca2+ stores, which can be mediated by sarco-
lemmal Ca2+ channels or by Ca2+ release from the stores.
Electrogenic features of the sarcolemmal channels also
determine the frequency of the Ca2+ transients (Movie
S6). As a characteristic of pacemaker cells, we confirmed
that hyperpolarization-activated, cyclic nucleotide-gated
(HCN) channels modulated the rate of the Ca2+ transients.
The application of the HCN channel blocker ZD 7288 time
dependently reduced the frequency of Ca2+ transients in
iSABs (Figure 5A). In addition, the frequencies of Ca2+m Cell Reports j Vol. 2 j 592–605 j May 6, 2014 j ª2014 The Authors 595
Figure 3. Phenotypic Appearance and Marker Expression of Pacemaker-like Cardiomyocytes Obtained from iSABs
(A) Beating frequencies during the generation of aCaBs and iSABs; 300–400 bpm were achieved via a combination of TBX3 programming,
antibiotic selection, and an additional dissociation step (iSABs). The data represent five independent experiments and are presented as
means ± SD; *p < 0.05, **p < 0.01 ***p < 0.001. See also Movies S1, S2, S3, S4, and S5.
(B) Expression of HCN4 (left panel), Cx45 (middle panel), and Cx30.2 (right panel) in iSABs (red stainings). Counterstaining for Actin
(green) and nuclei (blue). Scale bar, 10 mm.
(C) Typical spindle and spider cellular shape of nodal cells derived from iSABs and subjected to electrophysiological analysis. Arrows
indicate patch-clamp pipette (out of focus). Scale bar, 50 mm. See also Movie S5.
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L-type voltage-sensitive Ca2+ channels. Correspondingly,
the spontaneous frequencies of the Ca2+ transients were
dramatically reduced after inhibition of L-type Ca2+ chan-
nels with nifedipine, and moderately by inhibition of
T-type Ca2+ channels with mibefradil in iSAB-derived cells
(Figure 5B).
A functional sarcoplasmic reticulum (SR) characterizes the
maturation state of cardiomyocytes. Therefore, in pace-596 Stem Cell Reports j Vol. 2 j 592–605 j May 6, 2014 j ª2014 The Authorsmaker cells, Ca2+ from SR plays an important role in sponta-
neous activity. The impact of Ca2+ from the SR on sponta-
neous Ca2+ transients becomes evident if a complete
release of Ca2+ from SR with caffeine or an inhibition of
SERCA with thapsigargin is induced. In iSAB-derived cells,
caffeine-induced SR-Ca2+ release increased the diastolic
Ca2+ level comparable to a Ca2+ peak, but with recognizable
spontaneous Ca2+ transients in the time course of the Ca2+
peak and unchanged systolic Ca2+ values (Figure S3A).
Figure 4. Electrophysiological Parame-
ters of Pacemaker-like Cardiomyocytes
Obtained from iSABs
(A) Distribution of pacemaker cells as
shown by single-cell patch-clamp and
funny-channel measurements: >81% of
pacemaker-like cells were achieved; 19% of
these represented immature pacemaker
cells and the rest were mature pacemaker
cells (n = 65). The data represent seven
independent experiments and are presented
as means ± SD. See also Tables S1–S3.
(B) Patch-clamp protocol. Voltage was
applied to elicit the hyperpolarization-
activated current for If recordings from
isolated iSAB cells.
(C) Example of If current, recorded from an
isolated iSAB-derived cell.
(D and E) Current density (D) and time
constant of activation (E) at –130 mV,
demonstrating a robust If expression with
slow activation kinetics typical of the
HCN4 channel subtype and mature SA nodal
If (n = 17). The data represent three inde-
pendent experiments and are presented as
means ± SD.
(F) Reaction to b-adrenergic (isoprotenerol) and muscarinic (carbachol) stimulation leads to typical accelerated versus decelerated AP
rates. iSAB-derived cells show a pronounced response to isoprotenerol, with beating rates reaching up to 560 bpm. iSAB/Iso: n = 9;
iSAB/Carb: n = 5. The data represent seven independent experiments and are presented as means ± SD.
See also Figures S1 and S2.
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notbedetected inaCaB-derivedcells.BlockingCa2+ reuptake
into SR by thapsigargin resulted in an increase of the
diastolic Ca2+ level only in iSAB-derived cells (Figure S3B).
The main proportion of Ca2+ underlying the Ca2+ tran-
sients is derived from the extracellular space. Therefore,
replacement of extracellular Ca2+ leads to an abolishment
of Ca2+ transients. When sarcolemmal Ca2+ flux was elim-
inated by blocking the Na+/Ca2+ exchanger and the Ca2+
channels, only intracellular Ca2+ cycling could be detected.
In this case, the application of caffeine induced a Ca2+ peak
in iSAB-derived cells that was 4-fold greater than in aCaB-
derived cells (Figures 5C and S3C). Additional inhibition
of SERCA under these conditions revealed a leaky SR in
iSAB-derived cells. The rate of intracellular Ca2+ accumula-
tion was increased 4-fold compared with no SERCA inhibi-
tion. After addition of caffeine 5 min after thapsigargin
incubation, the Ca2+ peak was reduced by a factor of 4. In
contrast, the caffeine-induced Ca2+ peak was identical
with andwithout SERCA inhibition in control cells (Figures
5C and S3C), where an intracellular Ca2+ accumulation also
could not be detected.
To ultimately test the functional pacemaker activity of
the iSABs, we took advantage of the ex vivo model basedSteon cultivated ventricular slices of murine hearts (Halbach
et al., 2006; Figure 6A). Although such slices typically
have spontaneous beating activity immediately after prep-
aration, they can be induced to robustly contract at up
to60 bpm via electrodes and are therefore an ideal system
for testing the functionality of our iSABs. Correspondingly,
when seeded on the slices, the iSABswere able to attach and
persist on the slices as shown by labeling with DiI (d.n.s.).
To address the effect of iSAB seeding, we first carefully
quantified spontaneous slice activity in naive slices.
On day 2 after slice preparation, a maximum of 70% of
slices containing at least one area of spontaneous beating
activity was observed. This value decreased dramatically
on days 3 and 4 (Figure 6B). Yet, whereas coculturing slices
with aCaBs did not significantly alter the number of beating
areas or beating parameters compared with naive slices,
seeding slices with iSABs resulted in a 1.5-fold increased
beatingactivity as early asdays1and2.Moreover, only slices
cocultured with iSABs preserved their spontaneous beating
activity and multiple beating sites also on days 3 and 4
(Figures 6B and 6C). Furthermore, the beating rates of
iSAB-seeded slices continuously and significantly increased
over 4-fold fromday 1 until day 4 (Figure 6D), whichwe did
not observe for unseeded and aCaB seeded slices.m Cell Reports j Vol. 2 j 592–605 j May 6, 2014 j ª2014 The Authors 597
Figure 5. Calcium Characteristics of
Pacemaker-like Cardiomyocytes Obtained
from iSABs
(A) Frequencies of spontaneous Ca2+ tran-
sients in iSAB cells significantly decrease
after inhibition of HCN channels via
ZD7288. The data represent four indepen-
dent experiments and are presented as
means ± SEM; nR 7.
(B) Frequencies of spontaneous Ca2+ tran-
sients in iSAB cells significantly decrease
after inhibition of T-type and L-type Ca2+
channels via mibefradil and nifedipine. The
data represent four independent experi-
ments and are presented as means ± SEM; n
> 12; *p < 0.05. See also Movie S6.
(C) Analysis of SR Ca2+ efflux as a charac-
teristic of pacemaker-active cells reveals an
enhanced rate of intracellular Ca2+ accu-
mulation in iSAB-derived cells (red) in
comparison with aCaBs (blue). Na+/Ca2+
exchanger blockade plus inhibition of
SERCA caused an intracellular Ca2+ accu-
mulation comparable to the reduction of
the caffeine peak in iSAB-derived cells. The
rate of cytosolic Ca2+ accumulation and
amplitude of the caffeine peak in aCaBs do
not show a difference. The data represent
five independent experiments and are pre-
sented as means ± SEM; #p < 0.05 versus no
SERCA inhibition; *p < 0.05 versus controls.
See also Figure S3.
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to the slice confirmed the formation of syncytia between
iSABs and slice cells, as shown by transmission of the dye
over time (Figure 6E). The same iSAB is shown in Figure 6E
and Movie S7, demonstrating pacing of the host slice
within the respective area. Furthermore, functional
coupling is evident from synchronized Ca2+ transients
between iSAB and slice myocardium. Therefore, peaks of
Ca2+ transients within the slice are smaller but highly
synchronous to spontaneous iSAB activity and can be
detected within a radius of 200 mm (Figure 6F; Movie
S8). Thus, the signals were derived from the slice myocar-
dium, especially since no significant outgrowths of iSABs
into the slice were observed in staining for the pacemaker
cell marker HCN4 (Figure 6G).DISCUSSION
The ability to produce de novo, highly enriched, stem cell-
derived populations of cardiac pacemaker cells that bear all
the functional parameters of mature nodal cells is of great598 Stem Cell Reports j Vol. 2 j 592–605 j May 6, 2014 j ª2014 The Authorsinterest for future cell-based therapies. Such cells might
be able to reconstitute a proper cardiac rhythm in the sense
of a biological pacemaker. In addition, drug testing in vitro
would benefit from the availability of such purified nodal
cells. PSCs are the focus of these goals because they have
been shown to give rise to any cell type of the mammalian
organism, including spontaneously beating cardiomyo-
cytes with molecular and functional properties character-
istic of SAN/pacemaker cells (Maltsev et al., 1994; He
et al., 2003; Yanagi et al., 2007; Barbuti et al., 2009; Ma
et al., 2011; David and Franz, 2012). Typically, however,
the cell populations within EBs are highly heterogeneous,
which inevitably leads to the requirement of reliable selec-
tion and isolation strategies. This applies in particular to
the very rare cell type of cardiac nodal cells.
Cardiac nodal cells are characterized by a low membrane
potential, diastolic depolarization, and low upstroke veloc-
ities. A number of currents contribute to diastolic depolar-
ization and to the AP in the SAN, including the pacemaker
current If. This current is carried by the HCN channel. The
cyclic-AMP binding site on the HCN channel permits cate-
cholamines to modulate activation, and this property
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maker mechanism (Rosen, 2005). There are four genes
representing the four known isoforms, termed HCN1–
HCN4. In the SAN, the predominant isoform by far is
HCN4 (Ishii et al., 1999; Stieber et al., 2004).
In this regard, murine ESC derivatives bearing EGFP tran-
scriptionally controlled via the promoter of theHCN4 gene
were reported to coexpress EGFP, HCN4, and other cardiac
markers in spontaneously beating foci (Morikawa et al.,
2010). Yet, after the EGFP-positive fraction was subjected
to cell sorting, spontaneous APs were rarely observed and,
interestingly, most of the cells were positive for nestin, a
marker for neurons (Morikawa et al., 2010). This corre-
sponds to the observation that HCN4 is a marker not
only for spontaneously active cardiomyocytes but also for
nerve cells (Garcia-Frigola et al., 2003).
Therefore, alternative promising approaches based on
endogenous surface markers (Scavone et al., 2013) and
pharmacological administration of small molecules (Wiese
et al., 2011; Kleger et al., 2010) have been pursued in addi-
tion to direct reprogramming strategies (Bakker et al., 2012;
Kapoor et al., 2013).
Here, we describe a protocol that combines ESC forward
programming using TBX3 as a key transcription factor with
Myh6-based antibiotic selection (Klug et al., 1996). This
approach consistently led to highly effective generation
of nodal-like pacemaker cell aggregates characterized by
spontaneously contracting cardiomyocytes with highly
synchronized beating rates of 300–400 bpm, approxi-
mating those of a mouse heart. Most (>80%) of the cardio-
myocytes within these clusters clearly represented the
nodal cell type, and, to our knowledge, such high purities
have not been achieved before (Kleger et al., 2010; Wiese
et al., 2011; Scavone et al., 2013).
Although it is technically almost impossible to discrimi-
nate between murine SAN and AV node cells, especially on
the electrophysiological level, Marger et al. (2011) showed
that the two cell types differ in a more easily accessible
feature, namely, their spontaneous beating rates after isola-
tion. They observed rates of260 bpm in isolated SAN cells
and 175 bpm in AV node cells in culture. Isoproterenol
stimulation led to beating rates of 350 bpm in SAN cells
and 225 bpm in AV node cells. Our iSAB-derived cells
showed rates of 305 bpm and >550 bpm without
and with isoproterenol stimulation, respectively, thus
exceeding the values for SAN cells reported by Marger
et al. (2011). Moreover, as our cells provide all other prop-
erties required for full functionality (i.e., protein expression
patterns and electrophysiological and Ca2+ signaling
parameters), we propose to call these engineered pace-
maker aggregates induced sinoatrial bodies (iSABs).
Furthermore, our iSABs are functional in the sense that
they can robustly pace working myocardium ex vivo.SteOur initial experiments with TBX3-based programming
alone led to merely a doubling of functional pacemaker
cell numbers in cell aggregates with significantly lower
beating frequencies. This may correspond to the insuffi-
ciency of TBX3 for fully direct reprogramming of ventricu-
lar myocardium to pacemaker cells (Bakker et al., 2012).
Yet, the effect of TBX3 in ESCs was drastically further
enhanced when we introduced the additional Myh6
promoter-based antibiotic selection plus an additional
dissociation step (Figure 7). Our rationale for this was
based on recent reports describing the enrichment of
ventricular and nodal cardiomyocytes via Myh6-based
selection (Klug et al., 1996; Kensah et al., 2013; Otsuji
et al., 2010), although this method was originally thought
to enrich cardiomyocyte subtypes in an undirected
manner.
Our approach differs from those described in previous
studies, which simulated biological pacemakers by manip-
ulating terminal effector molecules underlying the sarco-
lemmal electrophysiology instead of de novo generating
fully functional nodal cells (Johns et al., 1995; Nuss
et al., 1999). In contrast, our protocol leads to cells that
exhibit not only electrical oscillations but also the subtle
electrophysiological and calcium signaling characteristics
and distinctive morphological features of endogenous
pacemaker cells. Our technology thus may become
important for future alternatives to electronic pacing
devices.
However, although our pacemaker cells formed a syn-
chronized and rapidly beating syncytium, and were
capable of electrically connecting to and pacing ventricular
slice cultures ex vivo, their potential to robustly engraft
intramyocardially and to pace at physiological beating
rates needs to be analyzed. Likewise, the transferability of
our protocol to human PSCs (i.e., human ESCs and induced
PSCs) (Gerecht-Nir et al., 2004; Takahashi and Yamanaka,
2006; Takahashi et al., 2007; Mauritz et al., 2008) remains
to be addressed. Combining this protocol with DNA-free
approaches such as RNA or protein transfections and
suitable endogenous surface markers may then bring it
closer to practical application.EXPERIMENTAL PROCEDURES
qRT-PCR
qRT-PCR was performed using RNA isolated via the RNeasy kit
(QIAGEN). First-strand cDNA was synthesized at 37C from 2 mg
RNA with AMV reverse transcriptase (Amersham) and random
hexamer primers. Real-time PCR was performed with an iCycler
and theMyiQ detection system (Bio-Rad) using the IQ Syber Green
Super Mix kit (Bio-Rad). Primers were designed using the DNA Star
software and the specificity of each primer pair was confirmed by
agarose gel electrophoresis. The annealing temperature was 57Cm Cell Reports j Vol. 2 j 592–605 j May 6, 2014 j ª2014 The Authors 599
(legend on next page)
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Figure 7. Flowchart for iSAB Generation
Cartoon displaying sequential steps for the generation of iSABs,
combining TBX3 programming with Myh6-promoter selection and
an additional cell-dissociation step.
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corresponded to bp 812–934 of Gapdh (forward primer:
50-TCTTGGGCTACACTGAGGAC-30; reverse primer: 50-ACCAGG
AAATGAGCTTGACA-30) and to bp 287–429 of TBX3 (forward
primer: 50-AAGAAGAGGTGGAGGACGAC-30; reverse primer:
50- CAGCCCAGAACATCTCACTT-30). All samples were analyzed
in duplicate, and total RNA pooled from undifferentiated and
differentiated ESCs as well as murine hearts was used as control
and to generate a standard curve for markers analyzed. As a nega-
tive control, total RNA from each of the samples was run without
reverse transcriptase. No signal was detected after 40 PCR cycles
in the absence of reverse transcriptase, indicating that all samples
were free of DNA contamination. In addition, no signal was
detected when reverse transcriptase was added but RNA template
was not, indicating that there was no contamination from exoge-
nous RNA or DNA. The standard curve for all genes displayed an
increase of one threshold cycle for each bisection of template
concentration. Evaluation of relative gene-expression levels was
performed based on the DDCT method. Factors of changes in
relative mRNA expression levels were calculated using Gapdh as a
reference gene, and the expression value in control cells was
defined as one.Figure 6. Functionality of iSABs in an Ex Vivo Model of Cultivate
(A) Ventricular slices were cultivated for 5 days (left) and MTT staini
(B) Percentage distribution of iSAB-seeded, aCaB-seeded, and nonse
Spontaneous activity ceased after day 2, whereas activity in iSAB-see
(C) Average number of active regions per iSAB-seeded, aCaB-seeded, a
experiments and are presented as means ± SEM; nR 15; *p < 0.05.
(D) Increase of beating frequencies of iSAB-seeded slices from day 1 un
presented as means ± SEM; nR 16; ***p < 0.05. See also Movie S7.
(E) Transmission of calcein dye from an iSAB to the recipient slice ov
(F) Stimulation of slice regions (white arrows) in the proximity of
transients.
(G) The identical iSAB/slice coculture as shown in (F) was stained for H
SteElectrophysiological Analyses
Spontaneously beating cardiac cells were isolated fromEBs for elec-
trophysiological analysis as previously described (David et al.,
2009, 2013). Briefly, beating areas of the EBs were excised under
a microscope and transferred to 37C prewarmed isolation buffer
containing 116 mM NaCl, 5 mM KCl, 0.8 mM MgSO4, 1 mM
NaH2PO4, 20 mM HEPES, and 5.5 mM glucose. The pH was
adjusted to 7.3 with NaOH. For enzymatic release of single cells,
the tissue pieces were incubated for 15min at 37C and with slight
shaking in isolation buffer with the addition of 0.5 mg/ml collage-
nase B (Roche) and 1 mg/ml pankreatin (GIBCO). Immediately
after incubation, the tissue pieces were mechanically dispersed in
isolation buffer/medium (Dulbecco’s modified Eagle’s medium
[DMEM] + 10% fetal calf serum [FCS; PAA], 1:1 v/v) and plated
on polylysated glass coverslips. iSAB-derived cells for patch clamp-
ing were obtained via dissociation with 100% Accutase (Affime-
trix) for 15 min. In each case, the cells were allowed to settle for
5 min before medium was added. Cells were kept at 37C in 5%
CO2 for 12–24 hr before analyses.
Spontaneous APs and currents were recorded from contracting
cardiomyocytes at 37C in the perforated patch configuration
using a MultiClamp 700B amplifier and pClamp10 software
(Molecular Devices). Offline data analysis was done with Clampfit
software (Molecular Devices) or Origin 6.0 software (Microcal).
Patch pipettes were pulled from borosilicate glass and heat
polished. They had a resistance of 2–5 MU when filled with intra-
cellular solution containing 10 mM NaCl, 130 mM potassium
aspartate, 0.04 mM CaCl2, 3 mM Mg-ATP, 10 mM HEPES, and
200 mg/ml amphotericin B, pH adjusted to 7.2 with KOH. The
extracellular (bath) solution contained 140 mM NaCl, 5.4 mM
KCl, 1 mMMgCl2, 1.8 mM CaCl2, 5 mM HEPES, 5.5 mM glucose,
pH adjusted to 7.4withNaOH. For better If recordings, 2mMBaCl2
and 0.3 mM CdCl2 were sometimes added to the bath solution to
block IKI and ICa. These measurements were done at room
temperature (RT). If was measured by stepping from a holding
potential of –40 mV to test potentials between –130 mV
and +20 mV. The current amplitude after 3 s during the –130 mV
pulse was divided by the cell capacitance to calculate the current
(If) density. To determine If activation kinetics, the time constant
of activation (t) was obtained by fitting the current trace of
the 130 mV step after the initial lag with the sum of two expo-
nential functions: y = A1e
(x/t1) + A2e
(x/t2), where t1 and t2 are
the fast and slow time constants of activation, respectively; t1 isd Murine Ventricular Slices
ng was used to assess viability (right).
eded slices containing at least one contracting region over time.
ded slices was greatly retained (nR 15).
nd unseeded slices over time. The data represent three independent
til day 4. The data represent three independent experiments and are
er time. Scale bar, 200 mm.
an iSAB (red arrow) is accompanied by highly synchronized Ca2+
CN4 expressing the nodal cell marker in the iSAB. See also Movie S8.
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HCN channel activation generally accounts for <10% of the
current amplitude. Isoproterenol or carbachol (Sigma) were
directly dissolved in bath solution on the day of the experiment
and applied to the cells via a fast-exchange superfusion system.
APs were recorded with a 10 kHz sampling rate. Analyses were
done on the original traces. The slope of the linear fit of the
distance from the MDP to the threshold potential is the DDR. AP
duration is the time from threshold potential to MDP.Ca2+ Imaging
All Ca2+ transients were measured by fluorescence imaging micro-
scopy (Visitron Systems) and analyzed with VisiView imaging
software. Ca2+ signals were recorded at an emission wavelength
of 525/50 nm with an excitation wavelength of 470/40 nm
(50 ms) using a cooled digital CCD camera in 4 3 4 binning
mode. iSABs and aCaBs were loaded with 2.5 mM Fluo-4/acetoxy-
methyl ester (Fluo-4/AM) in differentiation medium at 37C for
30 min. After a second medium change, measurements were
carried out at a temperature of 28C. Ca2+ transients in ESCs are
expressed as acute value of fluorescence intensity (F) normalized
to minimal fluorescence intensity (Fo) during analyzed time.
Spontaneous Ca2+ transients were influenced by inhibition of
HCN channels with 5 mM ZD 7288 (Sigma-Aldrich), inhibition of
T-typevoltage-sensitiveCa2+ channelswith1mMmibefradil (Sigma-
Aldrich), and inhibition of L-type voltage-sensitive Ca2+ channels
with 1 mM nifedipine (Sigma-Aldrich). For experiments involving
blocking of sarcolemmal Ca2+ transport, the culture medium was
replaced by a tyrode solution in a composition of (in mM) LiCl
140, KCl 6, MgCl 1, glucose 10, EGTA 1, HEPES 5, pH 7.4 (adjusted
with KOH). The influence of the Ca2+ stores on the Ca2+ transients
was investigated by applying caffeine (10 mM; Sigma-Aldrich)
to open the ryanodine-receptor-coupled SR-Ca2+ channels, and
thapsigargin (2 mM; Sigma-Aldrich) to inhibit the SERCA. ZD
7288, nifedipine, and Fluo-4/AM were dissolved in DMSO (final
concentration < 0.1%) and thapsigargin in ethanol (final concen-
tration 0.2%). Mibefradil and caffeine were dissolved in H2O.Slice Preparation and Culture
The experimental protocols for animal experiments were approved
by the Bavarian Institutional Animal Care andUse Committee and
were conducted in accordance with the Guide for the Care andUse
of Laboratory Animals (NIH publication no. 85-23, revised 1996).
Hearts of adult mice from both sexes were rapidly removed and
transferred to ice-cold modified Tyrode’s solution containing (in
mM) NaCl 136, KCl 5.4, MgCl2 1, CaCl2 0.9, NaH2PO4 0.33,
glucose 10, 2,3-butanedione-monoxime 30, HEPES 5, pH 7.4
(adjusted with NaOH). Ventricles were dissected from the atria,
valves, and vessels, and embedded in 4% low-melt agarose gel dis-
solved in modified Tyrode’s solution without glucose. The agarose
block containing the heart was glued to the sample holder of the
vibratome (VT1200S; Leica) and quickly covered with ice-cold
Tyrode’s solution. The hearts were sectioned parallel to the valve
plane into 300-mm-thick tissue slices with steel blades (Wilkinson),
resulting in ring-shaped slices of the ventricular myocardium.
After an incubation of 30 min in ice-cold Tyrode’s solution, the
slices were transferred onto a Biopore membrane of tissue culture602 Stem Cell Reports j Vol. 2 j 592–605 j May 6, 2014 j ª2014 The Authorsinserts (Millicell; Millipore) for culturing at an air-media interface.
Tissue culture inserts were placed in Petri dishes containing culture
medium M199 supplemented with 1% insulin-transferrin-sele-
nium (GIBCO) and 1% penicillin/streptomycin (Sigma). Slices
were cultured in the incubator (37C, 5% CO2) until coculturing.
For routine determination of slice viability, slices were incubated
with thiazolyl blue tetrazolium bromide (MTT, 0.5 mg/ml; Sigma)
for 40 min at 37C and analyzed by light microscopy.
Coculture of iSABs with Cardiac Slices
iSABs were labeled with calcein red (AAT Bioquest) to monitor
living cells. iSABs were incubated with 10 mg/ml calcein red/AM
in differentiation medium for 30 min at 37C in the incubator.
After centrifugation (1,000 rpm, 5min) and resuspension in differ-
entiation medium, iSABs were placed on the cardiac murine slices
with a pipette under the microscope. iSABs and cardiac slices
were cocultured in the incubator (37C, 5% CO2). The beating
frequencies of iSABs and slice regions were recorded daily with a
Sony NEX-5N camera. Coupling between iSABs and slices was
detected by transmission of calcein red from iSABs into the cells
of slices using fluorescence imaging (Ex/Em 646/659 nm; Visitron
Systems). Contracting regions of iSABs with slices were recorded
every day and the distribution of the calcein red fluorescence
was analyzed visually.
Ca2+ Imaging in Contracting Regions of iSABs with
Slices
Slices with iSABs were loaded with 5 mM Fluo-4/AM (Invitrogen)
in M199 supplemented with 1% insulin-transferrin-selenium
(GIBCO) and 1% penicillin/ streptomycin (Sigma) at 37C for
30min. Ca2+ signals were recorded by fluorescence imagingmicro-
scopy (Visitron Systems) at an emission wavelength of 525/50 nm
with an excitation wavelength of 470/40 nm (exposition time
30 ms) using a cooled digital CCD camera in 4 3 4 binning
mode. All Ca2+ transients were analyzed with VisiView imaging
software and expressed as acute value of fluorescence intensity
(F) normalized to minimal fluorescence intensity (Fo) during
analyzed time (20 s) in the respective regions.
Cell Culture
ESC lines were derived from the murine line GSES (David et al.,
2005) and grown in high-glucose DMEM with stable glutamine
(GIBCO) containing 10% FBS Superior (Biochrom), 100 mM
nonessential amino acids (GIBCO), 1% penicillin/streptomycin
(GIBCO), and 100 mM b-mercaptoethanol (Sigma) in the presence
of 1,000 U/ml of LIF (Milllipore). Differentiation was performed
according to standard protocols in Iscove’s basal medium
(Biochrom) containing 10% FBS (Biochrom), 100 mMnonessential
amino acids (GIBCO), 1% penicillin/streptomycin (GIBCO), and
450 mM 1-thioglycerol (David et al., 2008). The cells were passaged
by trypsin/EDTA (GIBCO) at 70% confluence, which was usually
achieved after 2–3 days. Typically, three or four passages after
cell-thawing differentiation were induced. Transfections with
15 mg plasmid DNAwere performed on 10 cm tissue culture dishes
using JetPEI (Peqlab), with subsequent selection via 10 mg/ml
blasticidin (Invivogen) or 250 mg/ml hygromycin (Invitrogen).
Stable clones were picked manually, further cultivated, and tested
Stem Cell Reports
Programming and Isolation of Cardiac SAN Bodiesby qRT-PCR and differentiation assays (David et al., 2008).
Positively evaluated clones were subjected to antibiotic treatment
for cardiomyocyte enrichment as previously described (Klug et al.,
1996).
Generation of aCaBs and iSABs
Formation of aCaBs and iSABs was achieved as follows: Differenti-
ation was consistently performed in hanging-drop culture for
2 days using 1,000 cells as the starting material for one EB
in Iscove’s basal medium (Biochrom) containing 10% FBS
(Biochrom), 100 mM nonessential amino acids (GIBCO), 1% peni-
cillin/streptomycin (GIBCO), and 450 mM 1-thioglycerol. For an
additional 4 days, the cells were differentiated in suspension
culture, and at day 6 of differentiation, consistently 15 EBs were
seeded on one well of a 24-well plate. Antibiotic selection with
400 mg/ml G418 (Biochrom) was initiated at day 8 after seeding
and 4 days later, iSABs and aCaBs were isolated via treatment
with 6,000 U/ml collagenase IV (GIBCO) for 30 min.
To obtain single cells for subsequent experiments, the bodies
were further dissociated with 100% Accutase (Affimetrix) for
15 min.
To ensure successful generation of aCaBs and iSABs, potential
mycoplasma contamination was routinely controlled twice a
week using the PCR-based MycoSPY kit system (Biontex).
For quantification of spontaneously beating foci per EB, the
numbers of EBs successfully attached to the well were scored
1 day after plating. Based on this, beating foci per EB were counted
daily. Single beating foci were defined either as being clearly
spatially separated from each other or as having different beating
frequencies.
FACS Analysis
Cells were detached with trypsin/EDTA (GIBCO), fixed in 0.25%
formalin (Sigma), permeabilized in 0.1% Triton-X (Sigma), and
blocked with 2% BSA (Roth). Primary antibodies (SOX2, 1:200
[Abcam]; OCT4, 1:200 [Abcam]; and HCN4; 1:50 [Alamone
Labs]) and secondary antibodies (anti-mouse PE, 1:500 [Abnova];
anti-rabbit Alexa Fluor 488, 1:500 [Life Technologies]) were
incubated in blocking solution containing 0.01% saponin for
1 hr at RT. FACS analyses were performed with an Epics XL Flow
Cytometer (Beckman Coulter).
Immunostaining
Cells on coverslips were fixed in 4% paraformaldehyde (Sigma) for
1 hr at 4C, permeabilized with 0.1% Triton-X (Sigma), and
blocked with 0.2% cold-water fish skin gelatin (Sigma)/10% FCS
(GIBCO). All antibodies were incubated in blocking solution
plus 0.01% saponin (Sigma), primary antibodies (TBX3, 1:200
[Abnova]; a-MHC, 1:200; [Abcam]; HCN4, 1:100 [Alomone Labs];
Connexin 30.2, 1:200 [Abcam]; and Connexin 45, 1:200 [Abcam])
for 1 hr at RT, secondary antibodies (anti-sheep Alexa Fluor 633,
1:500 [Life Technologies]; anti-mouse Alexa Fluor 647, 1:500
[Abcam]; and anti-rabbit Alexa Fluor 647, 1:500 [Abcam]) for
45 min at RT with additional phalloidin (1:500; Enzo Life Science)
and bisBenzimide (DAPI, 1:2,000; Sigma). The coverslips were
mounted with Dako mounting medium (DAKO) to glass slides
and analyzed by fluorescence microscopy using a Leica SP-5Steconfocal laser scanning microscope (Leica Microsystems) or an
ELYRA PS.1 LSM 780 microscope (Carl Zeiss).Data analysis
The data represent at least three biological replicates and are
presented as means ± SD unless stated otherwise. Graphs and
calculations were prepared using GraphPad Prism 5.0 software.
Means were compared using the two-tailed Student’s t test.
Statistical significance was defined as p < 0.05 (*p < 0.05, **p <
0.01, ***p < 0.001).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, three tables, and
eightmovies and can be foundwith this article online at http://dx.
doi.org/10.1016/j.stemcr.2014.03.006.
ACKNOWLEDGMENTS
We thank Keyence, Germany, for assisting with the live micro-
scopy. We are grateful to Christiane Gross, Judith Arcifa, and Sus-
anne Gabriel for expert technical assistance and Andrea Agli for
performing the patch-clamp recordings. A.D. and W.M.F. wish to
thank the German Center for Cardiovascular Research (DZHK),
partner site Munich Heart Alliance, Munich, Germany, for its sup-
port. R.D. and W.-M.F. were supported by the BMBF (01GN0960)
and the DFG (DA 1296/2-1 and FR 705/14-2). Additional funding
was provided by the Else Kro¨ner Stiftung and the Fritz Bender
Stiftung.
Received: February 28, 2014
Revised: March 17, 2014
Accepted: March 18, 2014
Published: April 17, 2014REFERENCES
Bakker, M.L., Boink, G.J., Boukens, B.J., Verkerk, A.O., van den
Boogaard, M., den Haan, A.D., Hoogaars, W.M., Buermans, H.P.,
de Bakker, J.M., Seppen, J., et al. (2012). T-box transcription factor
TBX3 reprogrammesmature cardiacmyocytes into pacemaker-like
cells. Cardiovasc. Res. 94, 439–449.
Barbuti, A., Crespi, A., Capilupo, D., Mazzocchi, N., Baruscotti, M.,
and DiFrancesco, D. (2009). Molecular composition and func-
tional properties of f-channels in murine embryonic stem
cell-derived pacemaker cells. J. Mol. Cell. Cardiol. 46, 343–351.
David, R., and Franz, W.M. (2012). From pluripotency to distinct
cardiomyocyte subtypes. Physiology (Bethesda) 27, 119–129.
David, R., Groebner, M., and Franz, W.M. (2005). Magnetic cell
sorting purification of differentiated embryonic stem cells stably
expressing truncated human CD4 as surface marker. Stem Cells
23, 477–482.
David, R., Brenner, C., Stieber, J., Schwarz, F., Brunner, S., Vollmer,
M., Mentele, E., Mu¨ller-Ho¨cker, J., Kitajima, S., Lickert, H., et al.
(2008). MesP1 drives vertebrate cardiovascular differentiation
through Dkk-1-mediated blockade of Wnt-signalling. Nat. Cell
Biol. 10, 338–345.m Cell Reports j Vol. 2 j 592–605 j May 6, 2014 j ª2014 The Authors 603
Stem Cell Reports
Programming and Isolation of Cardiac SAN BodiesDavid, R., Stieber, J., Fischer, E., Brunner, S., Brenner, C., Pfeiler, S.,
Schwarz, F., and Franz, W.M. (2009). Forward programming of
pluripotent stem cells towards distinct cardiovascular cell types.
Cardiovasc. Res. 84, 263–272.
David, R., Schwarz, F., Rimmbach, C., Nathan, P., Jung, J., Brenner,
C., Jarsch, V., Stieber, J., and Franz, W.M. (2013). Selection of a
common multipotent cardiovascular stem cell using the 3.4-kb
MesP1 promoter fragment. Basic Res. Cardiol. 108, 312.
Garcia-Frigola, C., Shi, Y., and Evans, S.M. (2003). Expression of the
hyperpolarization-activated cyclic nucleotide-gated cation chan-
nel HCN4 during mouse heart development. Gene Expr. Patterns
3, 777–783.
Gerecht-Nir, S., Fishman, B., and Itskovitz-Eldor, J. (2004).
Cardiovascular potential of embryonic stem cells. Anat. Rec.
A Discov. Mol. Cell. Evol. Biol. 276, 58–65.
Halbach, M., Pillekamp, F., Brockmeier, K., Hescheler, J., Mu¨ller-
Ehmsen, J., and Reppel, M. (2006). Ventricular slices of adult
mouse hearts—a newmulticellular in vitro model for electrophys-
iological studies. Cell. Physiol. Biochem. 18, 1–8.
He, J.Q., Ma, Y., Lee, Y., Thomson, J.A., and Kamp, T.J. (2003). Hu-
man embryonic stem cells develop into multiple types of cardiac
myocytes: action potential characterization. Circ. Res. 93, 32–39.
Ishii, T.M., Takano, M., Xie, L.H., Noma, A., and Ohmori, H.
(1999). Molecular characterization of the hyperpolarization-
activated cation channel in rabbit heart sinoatrial node. J. Biol.
Chem. 274, 12835–12839.
Johns, D.C., Nuss, H.B., Chiamvimonvat, N., Ramza, B.M.,
Marban, E., and Lawrence, J.H. (1995). Adenovirus-mediated
expression of a voltage-gated potassium channel in vitro (rat
cardiac myocytes) and in vivo (rat liver). A novel strategy for
modifying excitability. J. Clin. Invest. 96, 1152–1158.
Kapoor, N., Liang, W., Marba´n, E., and Cho, H.C. (2013). Direct
conversion of quiescent cardiomyocytes to pacemaker cells by
expression of Tbx18. Nat. Biotechnol. 31, 54–62.
Kehat, I., Gepstein, A., Spira, A., Itskovitz-Eldor, J., andGepstein, L.
(2002). High-resolution electrophysiological assessment of human
embryonic stem cell-derived cardiomyocytes: a novel in vitro
model for the study of conduction. Circ. Res. 91, 659–661.
Kensah, G., Roa Lara, A., Dahlmann, J., Zweigerdt, R., Schwanke,
K., Hegermann, J., Skvorc, D., Gawol, A., Azizian, A., Wagner, S.,
et al. (2013). Murine and human pluripotent stem cell-derived
cardiac bodies form contractile myocardial tissue in vitro. Eur.
Heart J. 34, 1134–1146.
Kleger, A., Seufferlein, T., Malan, D., Tischendorf, M., Storch, A.,
Wolheim, A., Latz, S., Protze, S., Porzner, M., Proepper, C., et al.
(2010). Modulation of calcium-activated potassium channels
induces cardiogenesis of pluripotent stem cells and enrichment
of pacemaker-like cells. Circulation 122, 1823–1836.
Klug,M.G., Soonpaa,M.H., Koh,G.Y., and Field, L.J. (1996). Genet-
ically selected cardiomyocytes from differentiating embronic stem
cells form stable intracardiac grafts. J. Clin. Invest. 98, 216–224.
Kreuzberg,M.M., So¨hl, G., Kim, J.S., Verselis, V.K.,Willecke, K., and
Bukauskas, F.F. (2005). Functional properties of mouse con-
nexin30.2 expressed in the conduction system of the heart. Circ.
Res. 96, 1169–1177.604 Stem Cell Reports j Vol. 2 j 592–605 j May 6, 2014 j ª2014 The AuthorsMa, J., Guo, L., Fiene, S.J., Anson, B.D., Thomson, J.A., Kamp, T.J.,
Kolaja, K.L., Swanson, B.J., and January, C.T. (2011). High purity
human-induced pluripotent stem cell-derived cardiomyocytes:
electrophysiological properties of action potentials and ionic
currents. Am. J. Physiol. Heart Circ. Physiol. 301, H2006–H2017.
Maltsev, V.A.,Wobus, A.M., Rohwedel, J., Bader,M., andHescheler,
J. (1994). Cardiomyocytes differentiated in vitro from embryonic
stemcells developmentally express cardiac-specific genes and ionic
currents. Circ. Res. 75, 233–244.
Marger, L., Mesirca, P., Alig, J., Torrente, A., Dubel, S., Engeland, B.,
Kanani, S., Fontanaud, P., Striessnig, J., Shin, H.S., et al. (2011).
Pacemaker activity and ionic currents in mouse atrioventricular
node cells. Channels (Austin) 5, 241–250.
Mauritz, C., Schwanke, K., Reppel, M., Neef, S., Katsirntaki, K.,
Maier, L.S., Nguemo, F., Menke, S., Haustein, M., Hescheler, J.,
et al. (2008). Generation of functional murine cardiac myocytes
from induced pluripotent stem cells. Circulation 118, 507–517.
Morikawa, K., Bahrudin, U., Miake, J., Igawa, O., Kurata, Y.,
Nakayama, Y., Shirayoshi, Y., and Hisatome, I. (2010). Identifica-
tion, isolation and characterization of HCN4-positive pacemaking
cells derived from murine embryonic stem cells during cardiac
differentiation. Pacing Clin. Electrophysiol. 33, 290–303.
Nuss, H.B., Marba´n, E., and Johns, D.C. (1999). Overexpression of
a human potassium channel suppresses cardiac hyperexcitability
in rabbit ventricular myocytes. J. Clin. Invest. 103, 889–896.
Otsuji, T.G., Minami, I., Kurose, Y., Yamauchi, K., Tada, M., and
Nakatsuji, N. (2010). Progressivematuration in contracting cardio-
myocytes derived from human embryonic stem cells: Qualitative
effects on electrophysiological responses to drugs. Stem Cell Res.
(Amst.) 4, 201–213.
Rosen, M.R. (2005). 15th annual Gordon K. Moe Lecture. Biolog-
ical pacemaking: in our lifetime? Heart Rhythm 2, 418–428.
Scavone, A., Capilupo, D., Mazzocchi, N., Crespi, A., Zoia, S.,
Campostrini, G., Bucchi, A., Milanesi, R., Baruscotti, M., Benedetti,
S., et al. (2013). Embryonic stem cell-derived CD166+ precursors
develop into fully functional sinoatrial-like cells. Circ. Res. 113,
389–398.
Stieber, J., Hofmann, F., and Ludwig, A. (2004). Pacemaker chan-
nels and sinus node arrhythmia. Trends Cardiovasc. Med. 14,
23–28.
Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent
stem cells from mouse embryonic and adult fibroblast cultures
by defined factors. Cell 126, 663–676.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T.,
Tomoda, K., and Yamanaka, S. (2007). Induction of pluripotent
stem cells from adult human fibroblasts by defined factors. Cell
131, 861–872.
Verheijck, E.E., van Kempen, M.J., Veereschild, M., Lurvink, J.,
Jongsma, H.J., and Bouman, L.N. (2001). Electrophysiological
features of themouse sinoatrial node in relation to connexin distri-
bution. Cardiovasc. Res. 52, 40–50.
Wiese, C., Grieskamp, T., Airik, R., Mommersteeg, M.T., Gardiwal,
A., de Gier-de Vries, C., Schuster-Gossler, K., Moorman, A.F.,
Kispert, A., and Christoffels, V.M. (2009). Formation of the sinus
Stem Cell Reports
Programming and Isolation of Cardiac SAN Bodiesnode head and differentiation of sinus nodemyocardium are inde-
pendently regulated by Tbx18 and Tbx3. Circ. Res. 104, 388–397.
Wiese, C., Nikolova, T., Zahanich, I., Sulzbacher, S., Fuchs, J., Yama-
naka, S., Graf, E., Ravens, U., Boheler, K.R., and Wobus, A.M.
(2011). Differentiation induction of mouse embryonic stem cells
into sinus node-like cells by suramin. Int. J. Cardiol. 147, 95–111.
Wobus, A.M., Wallukat, G., and Hescheler, J. (1991). Pluripotent
mouse embryonic stem cells are able to differentiate into cardio-Stemyocytes expressing chronotropic responses to adrenergic and
cholinergic agents and Ca2+ channel blockers. Differentiation
48, 173–182.
Yanagi, K., Takano, M., Narazaki, G., Uosaki, H., Hoshino, T., Ishii,
T., Misaki, T., and Yamashita, J.K. (2007). Hyperpolarization-
activated cyclic nucleotide-gated channels and T-type calcium
channels confer automaticity of embryonic stem cell-derived
cardiomyocytes. Stem Cells 25, 2712–2719.m Cell Reports j Vol. 2 j 592–605 j May 6, 2014 j ª2014 The Authors 605
